Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

Boosting CNS axon regeneration by circumventing limitations of natural cytokine signaling.
A review of Neuropharmacology Effects of Nigella sativa and Its Main Component, Thymoquinone.
Chronic pain disrupts the reward circuitry in multiple sclerosis.
Evaluation of Methods for the Inclusion of Real World Evidence in Network Meta-Analysis - A Case Study in Multiple Sclerosis.
Glial progenitor cell-based treatment of the childhood leukodystrophies.
Sodium intake is associated with increased disease activity in multiple sclerosis.
The association of IL-18 gene promoter polymorphisms and the levels of serum IL-18 on the risk of multiple sclerosis.
Papers: 24 Jul 2015 - 31 Jul 2015
MicroRNAs targeting TGFβ signalling underlie the regulatory T cell defect in multiple sclerosis.
MS Research Roundup: September 29, 2014
Pharmacological management of spasticity in multiple sclerosis: Systematic review and consensus paper.
Astrocytes in multiple sclerosis.
ECTRIMS 2013 Day 2
The Impact of Adherence and Development of Neutralizing Antibodies to Interferons β on Treatment of Multiple Sclerosis in the Czech Republic.
The effect of postpartum intravenous immunoglobulins on the relapse rate among patients with multiple sclerosis.
Papers: 5 Feb 2016 - 12 Feb 2016
Short Term Reproducibility of a High Contrast 3-D Isotropic Optic Nerve Imaging Sequence in Healthy Controls.
Health Care Utilization and Costs of Medicaid Program Services for Patients Diagnosed with Multiple Sclerosis.
Efficacy of hematopoietic stem cell formultiple sclerosis, an evidence based meta-analysis.
Quantitative Susceptibility Mapping Indicates a Disturbed Brain Iron Homeostasis in Neuromyelitis Optica - A Pilot Study.
The Keap1-Nrf2-ARE Pathway As a Potential Preventive and Therapeutic Target: An Update.
Hippocampal expressions of metallothionein I/II and glycoprotein 96 in EAE-prone and EAE-resistant strains of rats.
Modelling the Persistence of Disease-Modifying Drug Treatment (DMT) and its Independent Drivers in Finnish Multiple Sclerosis (MS) Patients: Parametric Survival Modelling.
Behavioral assessment of neuropathic pain, fatigue, and anxiety in experimental autoimmune encephalomyelitis (EAE) and attenuation by interleukin-10 gene therapy.
Novel Insights into the Multiple Sclerosis Risk Gene ANKRD55.

Pages